Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Neoplasms 2Vascular Diseases 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pain 1Neuralgia 1Mouth Neoplasms 1Chronic Pain 1Adenoma, Islet Cell 1

Interventions

Sunitinib 4Everolimus 4Fluorouracil 3Temozolomide 2Streptozocin 2Octreotide 2Leucovorin 2Irinotecan 2sargramostim 1sapanisertib 1pasireotide 1napabucasin 1motesanib diphosphate 1montanide ISA 51 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1ibrutinib 1ganitumab 1cabozantinib 1batifiban 1aflibercept 1Wound Healing 1Thalidomide 1Taxes 1Sorafenib 1Salts 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenoma, Islet Cell × Plastic Surgery Procedures × Clear all
NCT06024343 2024-11-07

Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction

Fudan University

Phase NA Completed
230 enrolled
Gastrointestinal

Adenoma, Islet Cell, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡